LEEANN DAM: Open Payments
NPI 1275924169 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$283 in 3 payments from 3 companies in 2025. Trend: 2023 $128 · 2024 $34 · 2025 $283
Consulting: $235Food & beverage: $48
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | 1 | $175 |
| Biogen, Inc. | 1 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $48 |
Products named: ULTOMIRIS, TYSABRI, HYQVIA.
Industry payments across TX — which companies pay providers there.
